BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)  

3301 Agriculture Drive

Madison  Wisconsin  53716  U.S.A.
Phone: 608-441-8120 Fax: 608-441-8120


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Drug Discovery





 Company News
Cellectar Biosciences  (NVLT) Announces Intent To Adjourn Annual Meeting Of Stockholders 5/27/2015 9:09:29 AM
Cellectar Biosciences  (NVLT) Reports First Quarter 2015 Financial Results And Provides Update On Clinical Programs 5/21/2015 2:00:14 PM
Cellectar Biosciences  (NVLT) To Host Conference Call On May 21st To Discuss First Quarter 2015 Results And Provide Update On Development Programs 5/20/2015 2:05:54 PM
Cellectar Biosciences  (NVLT) Reschedules Release Of First Quarter Financials And Quarterly Conference Call 5/11/2015 4:43:57 PM
Cellectar Biosciences  (NVLT) To Host Conference Call On May 12th To Discuss First Quarter 2015 Results And Provide Update On Development Programs 5/5/2015 10:18:43 AM
Cellectar Biosciences  (NVLT) Initiates Proof-Of-Concept Trial Of I-131-CLR1404 In Multiple Myeloma 4/15/2015 3:13:43 PM
Cellectar Biosciences  (NVLT) Full-Year 2014 Financial Results And Recent Highlights 3/25/2015 7:43:57 AM
Cellectar Biosciences  (NVLT) To Host Conference Call On March 24th To Discuss Fourth Quarter And Full Year 2014 Results And Provide Update On Development Progress 3/17/2015 7:41:52 AM
Cellectar Biosciences  (NVLT) To Present At 27th Annual Roth Conference 3/4/2015 8:44:20 AM
Cellectar Biosciences  (NVLT) To Present At The 17th Annual BIO CEO & Investor Conference 2015 2/6/2015 10:23:47 AM
12345678910...